During the immune destruction of tumor cells, the release of melanocyte antigens leads to the destruction of the immune privilege of normal melanocytes, which may cause normal melanocytes to be attacked by CD8+ cytotoxic T cells (3–10), thereby inducing VLD. The gene discussed is CD8A; the disease is neoplasm.